Thus, these results indicate that the LRIG2-induced anti-cancer activities on endometrial carcinoma involve PI3K/AKT and EGFR activation followed by the regulation of MCL-1, BAK, BAX, and p21 expression. Here, PIK3CA is linked to endometrial carcinoma.